Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 5
1994 6
1995 5
1996 16
1997 18
1998 44
1999 75
2000 101
2001 98
2002 155
2003 170
2004 246
2005 261
2006 293
2007 334
2008 295
2009 291
2010 306
2011 324
2012 340
2013 354
2014 298
2015 347
2016 325
2017 304
2018 305
2019 255
2020 296
2021 322
2022 295
2023 298
2024 158

Text availability

Article attribute

Article type

Publication date

Search Results

6,225 results

Results by year

Filters applied: . Clear all
Page 1
Quetiapine for primary insomnia: Consider the risks.
Modesto-Lowe V, Harabasz AK, Walker SA. Modesto-Lowe V, et al. Cleve Clin J Med. 2021 May 3;88(5):286-294. doi: 10.3949/ccjm.88a.20031. Cleve Clin J Med. 2021. PMID: 33941603 Free article. Review.
The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the general population, possibly to avoid standard medications with known addictive qualities and adverse side effects. However, evidence to support …
The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the gene …
Quetiapine withdrawal: A systematic review.
Monahan K, Cuzens-Sutton J, Siskind D, Kisely S. Monahan K, et al. Aust N Z J Psychiatry. 2021 Aug;55(8):772-783. doi: 10.1177/0004867420965693. Epub 2020 Oct 16. Aust N Z J Psychiatry. 2021. PMID: 33059460
OBJECTIVE: Withdrawal from psychoactive medication such as quetiapine is a well-documented phenomenon. Despite the extensive use of quetiapine, there have been few studies into the presence of discontinuation symptoms. ...CONCLUSION: Discontinuation symptoms are an …
OBJECTIVE: Withdrawal from psychoactive medication such as quetiapine is a well-documented phenomenon. Despite the extensive use of …
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials.
Lin CY, Chiang CH, Tseng MM, Tam KW, Loh EW. Lin CY, et al. Eur Neuropsychopharmacol. 2023 Feb;67:22-36. doi: 10.1016/j.euroneuro.2022.11.008. Epub 2022 Dec 1. Eur Neuropsychopharmacol. 2023. PMID: 36463762
Quetiapine is a common off-label antipsychotic drug for treating insomnia. ...The pooled results showed that quetiapine improved sleep quality compared with placebo (SMD: -0.57 [95%CI: -0.75, -0.4]). ...
Quetiapine is a common off-label antipsychotic drug for treating insomnia. ...The pooled results showed that quetiapine improv
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
Gómez-Revuelta M, Pelayo-Terán JM, Juncal-Ruiz M, Vázquez-Bourgon J, Suárez-Pinilla P, Romero-Jiménez R, Setién Suero E, Ayesa-Arriola R, Crespo-Facorro B. Gómez-Revuelta M, et al. Int J Neuropsychopharmacol. 2020 Apr 23;23(4):217-229. doi: 10.1093/ijnp/pyaa004. Int J Neuropsychopharmacol. 2020. PMID: 31974576 Free PMC article. Clinical Trial.
The aim of this study is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, ziprasidone, and quetiapine in the treatment of first episode of psychosis at 3-year follow-up. ...A total of 376 first-episode drug-naive patients were ra …
The aim of this study is to compare the clinical effectiveness of olanzapine, risperidone, haloperidol, aripiprazole, ziprasidone, and qu
Quetiapine-Induced Acute-Onset Catatonia.
Soo A, Bastiampillai T, Dhillon R. Soo A, et al. Prim Care Companion CNS Disord. 2023 May 18;25(3):22cr03368. doi: 10.4088/PCC.22cr03368. Prim Care Companion CNS Disord. 2023. PMID: 37227393 Free article. No abstract available.
Quetiapine for schizophrenia.
Srisurapanont M, Disayavanish C, Taimkaew K. Srisurapanont M, et al. Cochrane Database Syst Rev. 2000;(2):CD000967. doi: 10.1002/14651858.CD000967. Cochrane Database Syst Rev. 2000. PMID: 10796560 Updated. Review.
While the incidences of extrapyramidal side effects are not different between quetiapine and placebo, side effects such as dizziness and dry mouth are more prevalent in the quetiapine treated group. ...REVIEWER'S CONCLUSIONS: The high dropout rates are a large probl …
While the incidences of extrapyramidal side effects are not different between quetiapine and placebo, side effects such as dizziness …
Effect of quetiapine on inflammation and immunity: a systematic review.
Ferrari M, Godio M, Martini S, Callegari C, Cosentino M, Marino F. Ferrari M, et al. Int J Psychiatry Clin Pract. 2023 Jun;27(2):196-207. doi: 10.1080/13651501.2022.2101928. Epub 2022 Aug 1. Int J Psychiatry Clin Pract. 2023. PMID: 35913757 Review.
Starting from this perspective, in the last few decades, a number of studies attempted to identify quetiapine effects on immune functions in order to highlight a possible additional effect of this drug in psychotic diseases, although no conclusive results were obtained. ME …
Starting from this perspective, in the last few decades, a number of studies attempted to identify quetiapine effects on immune funct …
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study.
Dubath C, Piras M, Gholam M, Laaboub N, Grosu C, Sentissi O, Gamma F, Solida A, von Gunten A, Conus P, Eap CB. Dubath C, et al. Pharmacopsychiatry. 2021 Nov;54(6):279-286. doi: 10.1055/a-1525-2820. Epub 2021 Aug 13. Pharmacopsychiatry. 2021. PMID: 34388836
INTRODUCTION: The atypical antipsychotic quetiapine is known to induce weight gain and other metabolic complications. The underlying mechanisms are multifactorial and poorly understood with almost no information on the effect of dosage. Concerns were thus raised with the r …
INTRODUCTION: The atypical antipsychotic quetiapine is known to induce weight gain and other metabolic complications. The underlying …
Dosing Recommendations for Quetiapine When Coadministered With HIV Protease Inhibitors.
Sampson MR, Cao KY, Gish PL, Hyon K, Mishra P, Tauber W, Zhao P, Zhou EH, Younis IR. Sampson MR, et al. J Clin Pharmacol. 2019 Apr;59(4):500-509. doi: 10.1002/jcph.1345. Epub 2018 Nov 19. J Clin Pharmacol. 2019. PMID: 30452774 Review.
The quetiapine dose was not reduced on ritonavir initiation in 90% of therapy episodes. ...The current dosing recommendations for use of quetiapine with strong CYP3A inhibitors (ie, 6-fold lower quetiapine dose) are appropriate and should be followed when …
The quetiapine dose was not reduced on ritonavir initiation in 90% of therapy episodes. ...The current dosing recommendations for use …
Who prescribes quetiapine in Denmark?
Højlund M, Rasmussen L, Olesen M, Munk-Olsen T, Pottegård A. Højlund M, et al. Br J Clin Pharmacol. 2022 Sep;88(9):4224-4229. doi: 10.1111/bcp.15388. Epub 2022 May 19. Br J Clin Pharmacol. 2022. PMID: 35535441 Free PMC article.
The second-generation antipsychotic quetiapine is commonly used off-label for its anxiolytic and hypnotic properties. ...In 2020, 92% of all quetiapine was dispensed outside hospitals and the average daily dispensed quantity of quetiapine per user corresponde …
The second-generation antipsychotic quetiapine is commonly used off-label for its anxiolytic and hypnotic properties. ...In 2020, 92% …
6,225 results